市場調查報告書

全球血管損傷治療市場:成長,趨勢,及預測

Vascular Injury Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921951
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
全球血管損傷治療市場:成長,趨勢,及預測 Vascular Injury Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 115 Pages
簡介

本報告提供全球全球血管損傷治療市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各治療·損傷·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 血管手術的發生率上升
    • 技術的進步
  • 市場阻礙因素
    • 伴隨治療的副作用
  • 波特的五力分析

第5章 市場區隔

  • 不同治療
    • 合成片修補成型術
    • 延髓外側/靜脈瘤
    • 側道移植
    • 血栓切除
    • 解剖負搭橋術
    • 其他
  • 各損傷
    • 血栓症
    • 挫傷/內膜瓣
    • 裂傷/離決斷
    • 痙攣
    • 動脈瘤·假性動脈瘤
    • 動靜脈瘺
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Cleveland Clinic
    • Massachusetts General Hospital
    • Heidelberg University Hospital
    • Royal Berkshire NHS Foundation Trust
    • Mayo Clinic Health System
    • Tenet Healthcare
    • Apollo Hospitals Enterprise Ltd.
    • Universal Health Services, Inc.
    • Mediclinic International
    • CHSPSC, LLC

第7章 市場機會及今後趨勢

目錄
Product Code: 67749

The rising occurrences of vascular casualties are amongst the critical factors in the development of the worldwide market for vascular injury treatment. Less than 80 percent of cases of vascular injury is most commonly caused by penetrating trauma in the U.S. peripheral vascular injuries, which is due to increased use of endovascular interventions for medical and diagnostic purposes. Approximately 30% of vascular casualties are minimal-energy injuries (stab wounds and others) whereas high-energy injuries account for over 50% of vascular injuries.

The rise in the number of injuries owing to the increase in road casualties, sports injuries, wounds, and brutality further drives the market for the treatment of vascular injury. The high school athletes alone account for 2 million incidents, 50,000 visits to the doctor, and 30,000 hospital admissions in the U.S. each year, as per the CDC (Centers for Disease Control and Prevention), which in turn, is further boosting the vascular injury treatment market.

Key Market Trends

Bypass Graft segment is Expected to Hold the Largest Market Share in the Vascular Injury Treatment Market

The dominant share is retained by the bypass graft segment owing to the attributes such as high incidence rates and health complications associated with vascular diseases. Stroke, arteriovenous malformation (AVM), peripheral artery disease (PAD), carotid artery disease (CAD), abdominal aortic aneurysm (AAA), pulmonary embolism, critical limb ischemia (CLI), deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency (CVI) are the most severe vascular disorders which is also responsible for boosting the market growth during the forecast period.

As per the National Institutes of Health (NIH), about 14 million men and women across the country are affected by coronary heart disease. It is most common in people over 65 years old. The disease is caused by a waxy substance called a plaque that accumulates blood to the heart muscle within the arteries.

Bypass graft is the most common treatment for vascular injury to improve poor blood flow to the heart. This surgery could reduce the risk of severe complications for individuals with obstructive coronary artery disease, a form of heart disease ischemic. Thus, the demand for bypass graft is increasing and will drive the market growth during the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to maintain its supremacy in the overall vascular injury treatment market, throughout the forecast period. The increasing prevalence of vascular diseases is the major factor expected to drive the overall growth of the market, during the forecast period. Furthermore, there is a rise in geriatric population in the United States, which is expected to create more opportunities for the peripheral vascular treatment market in the region.

According to the estimates of the Center for Diseases Control and Prevention (CDC), approximately 8.5 million people in the United States suffer from peripheral artery diseases, which includes 12%-20% of individuals older than age 60 are also some of the main factors ensuring the dominance of the region.

Competitive Landscape

The vascular injury treatment market is highly competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making collaborations, and offering new treatment options with the other companies to consolidate their market positions across the globe.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Vascular Injury Surgeries
    • 4.2.2 Advancement in Technologies
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated with the Vascular Injury Treatment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Treatment
    • 5.1.1 Patch Angioplasty
    • 5.1.2 Lateral Arteriorrhaphy/ Venorrhaphy
    • 5.1.3 Bypass Graft
    • 5.1.4 Thrombectomy
    • 5.1.5 Extraanatomic Bypass
    • 5.1.6 Others
  • 5.2 By Injury
    • 5.2.1 Thrombosis
    • 5.2.2 Contusion/Intimal Flap
    • 5.2.3 Laceration/Transection
    • 5.2.4 Spasm
    • 5.2.5 Aneurysm and Pseudoaneurysm
    • 5.2.6 Arteriovenous (AV) Fistula
    • 5.2.7 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cleveland Clinic
    • 6.1.2 Massachusetts General Hospital
    • 6.1.3 Heidelberg University Hospital
    • 6.1.4 Royal Berkshire NHS Foundation Trust
    • 6.1.5 Mayo Clinic Health System
    • 6.1.6 Tenet Healthcare
    • 6.1.7 Apollo Hospitals Enterprise Ltd.
    • 6.1.8 Universal Health Services, Inc.
    • 6.1.9 Mediclinic International
    • 6.1.10 CHSPSC, LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS